<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Bioactive bacterial nanocellulose membranes for non-surgical debridement and infection prevention in burn wound healing</dc:title><dc:creator>Jančič,	Urška	(Avtor)
	</dc:creator><dc:creator>Nacu,	Isabella	(Avtor)
	</dc:creator><dc:creator>Vereştiuc,	Liliana	(Avtor)
	</dc:creator><dc:creator>Rancan,	Fiorenza	(Avtor)
	</dc:creator><dc:creator>Gorgieva,	Selestina	(Avtor)
	</dc:creator><dc:subject>bacterial nanocellulose</dc:subject><dc:subject>Bromelain</dc:subject><dc:subject>Nisin</dc:subject><dc:subject>Carboxymethyl cellulose</dc:subject><dc:subject>antimicrobial function</dc:subject><dc:subject>bioactive</dc:subject><dc:subject>burn wound treatment</dc:subject><dc:description>Novel bioactive bacterial nanocellulose (BnC) membranes were developed for effective, non-surgical debridement and infection-prevention in burn wound healing. Membranes were modified in situ with carboxymethyl cellulose (CMC) and ex situ with the proteolytic enzyme bromelain (Br) and antimicrobial peptide nisin (N). Post-processing into stable cellulose nanocrystal dispersions (ζ = -26 mV), enables assembly of model films for demonstration of high, irreversible bromelain (95 %) and nisin (99.5 %) adsorption. The BnC-CMC and BnC-CMC-N membranes were in vitro cytocompatible for HaCaT cells and induced faster cell proliferation with cell viability exceeding 100 % after 24 h incubation. The innovative aspect of this study lies in the ex vivo evaluation using an advanced human skin explant model with induced burns, providing a realistic, physiologically relevant assessment of membrane performance. Ex vivo experiments indicated the cytocompatibility of the BnC-CMC membrane with no acute toxicity or skin irritation, while nisin presence resulted in moderate irritating effect. Notably, the BnC-CMC-Br membrane showed digestion of intercellular junctions in the epidermis, while not inducing acute toxicity and skin irritation. By leveraging this innovative ex vivo human skin model in novel BnC-based membranes testing, the study provides a crucial translational step, bridging in vitro assessments and clinical applications for burn wound treatment.</dc:description><dc:publisher>Elsevier </dc:publisher><dc:date>2025</dc:date><dc:date>2025-04-01 15:53:00</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>92364</dc:identifier><dc:identifier>UDK: 677.46:620.3</dc:identifier><dc:identifier>COBISS_ID: 231067907</dc:identifier><dc:identifier>DOI: 10.1016/j.carpta.2025.100762</dc:identifier><dc:identifier>ISSN pri članku: 2666-8939</dc:identifier><dc:language>sl</dc:language><dc:rights>© 2025 The Author(s)</dc:rights></metadata>
